关注
Xinran Ma
Xinran Ma
在 cumc.columbia.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR
X Ma, L Long, S Moon, BJS Adamson, SS Baxi
Medrxiv, 2020.03. 16.20037143, 2020
3072020
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
ME Roberts, SA Jackson, LR Susswein, N Zeinomar, X Ma, ML Marshall, ...
Genetics in Medicine 20 (10), 1167-1174, 2018
1522018
Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk
MB Terry, MB Daly, KA Phillips, X Ma, N Zeinomar, N Leoce, GS Dite, ...
JNCI: Journal of the National Cancer Institute 111 (3), 331-334, 2019
422019
Characterization of a real-world response variable and comparison with RECIST-based response rates from clinical trials in advanced NSCLC
X Ma, L Bellomo, K Magee, CS Bennette, O Tymejczyk, M Samant, ...
Advances in therapy 38, 1843-1859, 2021
292021
Comparison of real-world response rate (rwRR) to RECIST-based response rate in patients with advanced non-small cell lung cancer (aNSCLC)
X Ma, NC Nussbaum, K Magee, AB Bourla, M Tucker, L Bellomo, ...
Annals of Oncology 30, v651, 2019
192019
Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR. medRxiv. 2020: 2020.03. 16.20037143
X Ma, L Long, S Moon, BJS Adamson, SS Baxi
Preprint, not peer-reviewed, 2022
172022
Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR. medRxiv, 2020.03. 16.20037143
X Ma, L Long, S Moon, BJS Adamson, SS Baxi
Accessed 10th Feb, 2022
142022
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies
BJS Adamson, X Ma, SD Griffith, EM Sweeney, S Sarkar, AB Bourla
Pharmacoepidemiology and Drug Safety 31 (1), 46-54, 2022
102022
The steroid metabolome and breast cancer risk in women with a family history of breast cancer: the novel role of adrenal androgens and glucocorticoids
LC Houghton, RE Howland, Y Wei, X Ma, RD Kehm, WK Chung, ...
Cancer Epidemiology, Biomarkers & Prevention 30 (1), 89-96, 2021
102021
Evaluating the impact of oncology care model reporting requirements on biomarker testing and treatment
EH Castellanos, A Orlando, X Ma, RB Parikh, G O’Connell, NJ Meropol, ...
JCO Oncology Practice 16 (10), e1216-e1221, 2020
82020
Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR [preprint published online May 30, 2020]
X Ma, L Long, S Moon, BJS Adamson, SS Baxi
medRxiv, 0
6
Concordance of clinician-documented and imaging response in patients with stage IV non–small cell lung cancer treated with first-line therapy
X Ma, L Bellomo, I Hooley, T Williams, M Samant, K Tan, B Segal, ...
JAMA Network Open 5 (5), e229655-e229655, 2022
52022
Using time-varying quantile regression approaches to model the influence of prenatal and infant exposures on childhood growth
Y Wei, X Ma, X Liu, MB Terry
Biostatistics & Epidemiology 1 (1), 133-147, 2017
32017
Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets
BA McKelvey, E Garrett-Mayer, AJ Belli, TD Brown, J Dow, JL Espirito, ...
Journal of Clinical Oncology 41 (16_suppl), 6595-6595, 2023
12023
Abstract C082: Prenatal exposure to polycyclic aromatic hydrocarbons and altered DNA methylation in breast cancer-related genes
N Zeinomar, HC Wu, X Ma, JB Herbstman, FP Perera, RL Miller, MB Terry
Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), C082-C082, 2020
12020
Impact of Oncology Care Model (OCM) reporting requirements on quality of care.
E Castellanos, A Orlando, J Hamrick, X Ma, G O'Connell, NJ Meropol, ...
Journal of Clinical Oncology 37 (15_suppl), 6620-6620, 2019
12019
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non–Small Cell Lung Cancer …
BA McKelvey, E Garrett-Mayer, DR Rivera, A Alabaster, HS Andrews, ...
JCO Clinical Cancer Informatics 8, e2400091, 2024
2024
Impacts of the COVID-19 pandemic on assessment of progression and surveillance bias in advanced non-small cell lung cancer
LE Johns, Y Zhao, X Ma, RA Miksad, SD Griffith
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 450-450, 2022
2022
Cover Image, Volume 31, Issue 1
BJS Adamson, X Ma, SD Griffith, EM Sweeney, S Sarkar, AB Bourla
Pharmacoepidemiology and Drug Safety 31 (1), i-i, 2022
2022
Abstract PD6-05: Withdrawn
RD Kehm, KA Phillips, MB Daly, IL Andrulis, Y Liao, X Ma, N Zeinomar, ...
Cancer Research 79 (4_Supplement), PD6-05-PD6-05, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20